{"transactions":[{"id":1177771,"issuer":{"id":8764,"kind":"organization","name":"IO Biotech, Inc."},"owners":[{"id":81064,"kind":"person","name":"Zocca Mai-Britt","position":1,"cik":"0001890736","reported_name":"Zocca Mai-Britt","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-04-04T16:18:15.000Z","date":"2025-04-02","kind":"grant","planned":false,"acquired":true,"shares":580000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-fourth of these options vest on April 2, 2026, and 1/36th of the remaining options vest each month thereafter, subject to the reporting person's continued service through the applicable vesting date, and subject to 25% acceleration upon termination of service by the issuer without cause and 100% acceleration upon termination of service by the Issuer without cause if such termination occurs within 24 months of a change of control."}],"balance_after":580000,"derivative":{"exercise_price":1.07,"expiration_date":"2035-04-02","underlying":"Common Stock","underlying_shares":580000},"source":{"system":"sec-edgar","filing":"0000905148-25-001096","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1890736/000090514825001096/form4.xml","form_type":"4"}},{"id":1323020,"issuer":{"id":8764,"kind":"organization","name":"IO Biotech, Inc."},"owners":[{"id":81064,"kind":"person","name":"Zocca Mai-Britt","position":1,"cik":"0001890736","reported_name":"Zocca Mai-Britt","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-12-23T18:56:14.000Z","date":"2024-12-23","kind":"purchase","planned":false,"acquired":true,"shares":12500,"price":0.8096,"value":10120.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The actual purchase price is $0.809556 per share of Common Stock, which has been rounded due to systematic character limitations."}],"balance_after":49891,"source":{"system":"sec-edgar","filing":"0000905148-24-003412","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1890736/000090514824003412/form4.xml","form_type":"4"}},{"id":1572714,"issuer":{"id":8764,"kind":"organization","name":"IO Biotech, Inc."},"owners":[{"id":81064,"kind":"person","name":"Zocca Mai-Britt","position":1,"cik":"0001890736","reported_name":"Zocca Mai-Britt","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-03-18T16:27:32.000Z","date":"2024-03-15","kind":"grant","planned":false,"acquired":true,"shares":750000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-fourth of these options vest on March 15, 2025, and 1/36th of the remaining options vest each month thereafter, subject to the reporting person's continued service through the applicable vesting date, and subject to 25% acceleration upon termination of service by the issuer without cause and 100% acceleration upon termination of service by the Issuer without cause if such termination occurs within 24 months of a change of control."}],"balance_after":750000,"derivative":{"exercise_price":1.65,"expiration_date":"2034-03-15","underlying":"Common Stock","underlying_shares":750000},"source":{"system":"sec-edgar","filing":"0000905148-24-000970","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1890736/000090514824000970/form4.xml","form_type":"4"}},{"id":1812199,"issuer":{"id":8764,"kind":"organization","name":"IO Biotech, Inc."},"owners":[{"id":81064,"kind":"person","name":"Zocca Mai-Britt","position":1,"cik":"0001890736","reported_name":"Zocca Mai-Britt","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Warrants (Right to Buy)","published_at":"2023-08-09T20:43:49.000Z","date":"2023-08-09","kind":"grant","planned":false,"acquired":true,"shares":37037,"price":0.125,"value":4629.625,"ownership":{"direct":true},"footnotes":[{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"These Warrants expire at 5:00 p.m. Eastern time on the earlier of (i) February 9, 2027, and (ii) one day prior to the closing of an Acquisition of the Issuer, as defined in the Form of Warrant, attached as Exhibit 4.1 to the Issuer's Current Report on Form 8-K, filed with the Securities and Exchange Commission on August 7, 2023."}],"balance_after":37037,"derivative":{"exercise_price":2.47,"exercise_date":"2023-08-09","underlying":"Common Stock","underlying_shares":37037},"source":{"system":"sec-edgar","filing":"0001140361-23-038881","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1890736/000114036123038881/form4.xml","form_type":"4"}},{"id":1812198,"issuer":{"id":8764,"kind":"organization","name":"IO Biotech, Inc."},"owners":[{"id":81064,"kind":"person","name":"Zocca Mai-Britt","position":1,"cik":"0001890736","reported_name":"Zocca Mai-Britt","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-08-09T20:43:49.000Z","date":"2023-08-09","kind":"grant","planned":false,"acquired":true,"shares":37037,"price":1.9,"value":70370.3,"ownership":{"direct":true},"balance_after":37391,"source":{"system":"sec-edgar","filing":"0001140361-23-038881","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1890736/000114036123038881/form4.xml","form_type":"4"}},{"id":1941898,"issuer":{"id":8764,"kind":"organization","name":"IO Biotech, Inc."},"owners":[{"id":81064,"kind":"person","name":"Zocca Mai-Britt","position":1,"cik":"0001890736","reported_name":"Zocca Mai-Britt","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-03-22T16:34:51.000Z","date":"2023-03-20","kind":"grant","planned":false,"acquired":true,"shares":500000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-fourth of these options vest on March 20, 2024, and 1/36th of the remaining options vest each month thereafter, subject to the reporting person's continued service through the applicable vesting date, and subject to 50% acceleration upon a change of control and subject to 100% acceleration upon termination of service by the Issuer without cause within 24 months of a change of control."}],"balance_after":500000,"derivative":{"exercise_price":1.98,"expiration_date":"2033-03-20","underlying":"Common Stock","underlying_shares":500000},"source":{"system":"sec-edgar","filing":"0001140361-23-013081","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1890736/000114036123013081/form4.xml","form_type":"4"}},{"id":2515600,"issuer":{"id":8764,"kind":"organization","name":"IO Biotech, Inc."},"owners":[{"id":81064,"kind":"person","name":"Zocca Mai-Britt","position":1,"cik":"0001890736","reported_name":"Zocca Mai-Britt","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Class A Stock","published_at":"2021-11-12T16:15:54.000Z","date":"2021-11-09","kind":"exercise","acquired":false,"shares":26580,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Zocca Consulting ApS"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Upon the closing of the Issuer's initial public offering, each share of Class A Stock beneficially owned by the reporting person automatically converted, for no additional consideration, into the number of shares of Common Stock reported in Column 7 of Table II. These shares of Class A Stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Upon the closing of the Issuer's initial public offering, each share of Class A Stock beneficially owned by the reporting person automatically converted, for no additional consideration, into the number of shares of Common Stock reported in Column 7 of Table II. These shares of Class A Stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Upon the closing of the Issuer's initial public offering, each share of Class A Stock beneficially owned by the reporting person automatically converted, for no additional consideration, into the number of shares of Common Stock reported in Column 7 of Table II. These shares of Class A Stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The reporting person is the sole owner of Zocca Consulting ApS and, in such capacity, may be deemed to beneficially own the shares held directly by Zocca Consulting ApS. The reporting person disclaims beneficial ownership of the shares held directly by Zocca Consulting ApS except to the extent of his pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":26580},"source":{"system":"sec-edgar","filing":"0001140361-21-037654","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1890736/000114036121037654/form4.xml","form_type":"4"}},{"id":2515599,"issuer":{"id":8764,"kind":"organization","name":"IO Biotech, Inc."},"owners":[{"id":81064,"kind":"person","name":"Zocca Mai-Britt","position":1,"cik":"0001890736","reported_name":"Zocca Mai-Britt","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-11-12T16:15:54.000Z","date":"2021-11-09","kind":"exercise","acquired":true,"shares":26580,"ownership":{"direct":false,"nature":"Zocca Consulting ApS"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Upon the closing of the Issuer's initial public offering, each share of Class A Stock beneficially owned by the reporting person automatically converted, for no additional consideration, into the number of shares of Common Stock reported in Column 7 of Table II. These shares of Class A Stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The reporting person is the sole owner of Zocca Consulting ApS and, in such capacity, may be deemed to beneficially own the shares held directly by Zocca Consulting ApS. The reporting person disclaims beneficial ownership of the shares held directly by Zocca Consulting ApS except to the extent of his pecuniary interest therein."}],"balance_after":26580,"source":{"system":"sec-edgar","filing":"0001140361-21-037654","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1890736/000114036121037654/form4.xml","form_type":"4"}},{"id":2521631,"issuer":{"id":8764,"kind":"organization","name":"IO Biotech, Inc."},"owners":[{"id":81064,"kind":"person","name":"Zocca Mai-Britt","position":1,"cik":"0001890736","reported_name":"Zocca Mai-Britt","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-11-08T18:33:02.000Z","date":"2021-11-04","kind":"grant","acquired":true,"shares":414212,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These options vest in 1/48 monthly increments of the vesting commencement date of November 4, 2021, subject to the reporting person's continued service through the applicable vesting date, and subject to 50% acceleration upon a change of control and subject to 100% acceleration upon termination of service by the Issuer without cause or by the reporting person within 24 months of a change of control."}],"balance_after":414212,"derivative":{"exercise_price":14,"expiration_date":"2031-11-04","underlying":"Common Stock","underlying_shares":414212},"source":{"system":"sec-edgar","filing":"0001140361-21-037038","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1890736/000114036121037038/form4.xml","form_type":"4"}}]}